Trade Name: Norditropin

Following information is meant for : Wholesalers, Suppliers, Exporters, Doctors, CROs, Comparator Supplies, Hospitals, MOH Tender Supplies, Generic, Brand, Cooperate Sourcing, India, Institutional Buyers.

Manufacturer: Novo Nordisk

Presentation: INJECTION, SOLUTION, HUMAN PRESCRIPTION DRUG

Strength: 30 mg/3mL

Storage and handling

SOMATROPIN Recombinant Human Growth Hormone [EPC],Human Growth Hormone [CS]

Disclaimer
  1. These products are not for sale in US territories. We offer them for exports outside US territories to trade professionals or patients with a valid prescription.
  2. All trademarks, brands and service marks that appear on this website are the property of their respective owners. GNH India does not claim ownership of or any affiliation with, any third party trademarks, brand or service marks appearing on this website.
  3. Third party trademarks are used only for bona fide purposes to identify the products as being that of their respective owners, which constitutes fair use of the trademark under the Trademarks Act, 1999. No sponsorship or endorsement on the part of GNH India should be inferred from the display or use of these trademarks.
  4. Read more

GNH India is WHO GDP and ISO 9001 2015 Certified Pharmaceutical Wholesaler, Supplier, Exporters from India of somatropin (Norditropin) which is also known as Norditropin and Manufactured by Novo Nordisk. It is available in strength of 30 mg/3mL.

somatropin (Norditropin) is supplied for Tenders, Emergency imports, Un - licensed, Specials, Orphan drug, Name patient line, RLD supplies, Reference listed drugs, Comparator Drug, Bio-Similar, Innovator samples, For Clinical trials. Click to know price.

  • No data
  • No data
  • NORDITROPINis a recombinant human growth hormone indicated for:
  • Pediatricn- Array
  • Adult
  • No data
  • Pediatric Dosage -
  • Adult Dosage:n
  • NORDITROPINinjection is a clear and colorless solution available as follows:
  • NORDITROPIN injectionis available as ():
  • NORDITROPIN is contraindicated in patients with:
  • No data
  • Increased Risk of Neoplasms
  • Glucose Intolerance and Diabetes Mellitus
  • Intracranial Hypertension (IH)
  • Severe Hypersensitivity
  • Fluid Retention
  • Hypoadrenalism
  • Hypothyroidism
  • Slipped Capital Femoral Epiphysis in Pediatric Patients
  • Progression of Preexisting Scoliosis in Pediatric Patients
  • Pancreatitis
  • The following important adverse reactions are also described elsewhere in the labeling:
  • Common adverse reactions in adult and pediatric patients include: upper respiratory infection, fever, pharyngitis, headache, otitis media, edema, arthralgia, paresthesia, myalgia, peripheral edema, flu syndrome, and impaired glucose tolerance. ()
  • To report SUSPECTED ADVERSE REACTIONS, contact Novo Nordisk at 1-888-NOVO-444 (1-888-668-6444) or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
  • Table 2 includes a list of drugs with clinically important drug interactions when administered concomitantly with NORDITROPINand instructions for preventing or managing them.
  • Table 2: Clinically Important Drug Interactions with NORDITROPIN
  • Glucocorticoids
  • Pharmacologic Glucocorticoid Therapy and Supraphysiologic Glucocorticoid Treatment
  • Cytochrome P450-Metabolized Drugs
  • Oral Estrogen
  • Insulin and/or Other Hypoglycemic Agents
  • No data
  • No data
  • Short-term overdosage could lead initially to hypoglycemia and subsequently to hyperglycemia. Overdose with somatropin is likely to cause fluid retention. Long-term overdosage could result in signs and symptoms of gigantism and/or acromegaly consistent with the known effects of excess growth hormonen
  • NORDITROPIN(somatropin) for injection is a recombinant human growth hormone. It is a polypeptide of recombinant DNA origin and is synthesized by a special strain of bacteria that has been modified by the addition of a plasmid which carries the gene for human growth hormone. NORDITROPINcontains the identical sequence of 191 amino acids constituting the naturally occurring pituitary human growth hormone with a molecular weight of about 22,000 Daltons.
  • NORDITROPINis supplied as a sterile solution for subcutaneous use in ready-to-administer prefilled pens with a volume of 1.5 mL or 3 mL.
  • Each NORDITROPINcontains the following (see Table 3):n
  • Table 3
  • No data
  • Carcinogenicity and mutagenicity studies have not been conducted with NORDITROPIN.
  • Impairment of Fertility
  • In a rat study evaluating female fertility, animals were administered once daily subcutaneous doses of 0.1, 0.3, and 1.1 mg/kg NORDITROPINbeginning two weeks prior to mating, throughout mating and during the first 7 days of pregnancy. Delays in the time to mating were observed at doses greater than or equal to 0.3 mg/kg (approximately 3 times the maximum adult clinical dose of 0.016 mg/kg, based on body surface area), but these doses were also associated with increases in the number of corpora lutea and implantations. A decrease in the pregnancy rate was observed at the dose of 1.1 mg/kg (approximately 10 times the clinical dose of 0.016 mg/kg, based on body surface area). Male fertility parameters have not been evaluated with administration of NORDITROPIN.
  • No data
  • NORDITROPINinjection is a clear and colorless solution available as FlexPro prefilled pens:
  • Each NORDITROPIN FlexPro pen is for use by a single patient. A NORDITROPIN FlexPro pen must never be shared between patients, even if the needle is changed.
  • Unused NORDITROPINFlexPro prefilled pensmust be stored at 2u00b0C to 8u00b0C/36u00b0F to 46u00b0F (refrigerator). Do not freeze. Avoid direct light.
  • Table 14 u2013 Storage Conditions and Expiration
  • Arrayn- See FDA-approved patient labeling.
  • Advise the patient to read the FDA-approved patient labeling (Patient Information and Instructions for Use).
  • Novo Nordisk is a registered trademark of Novo Nordisk A/S.
  • NORDITROPIN and FlexPro are registered trademarks of Novo Nordisk Health Care AG.
  • u00a9 2002-2018 Novo Nordisk Health Care AG
  • For information contact:
  • Novo Nordisk Inc.
  • 800 Scudders Mill Road
  • Plainsboro, New Jersey 08536, USA
  • 1-888-668-6444
  • Manufactured by:
  • Novo Nordisk A/S
  • DK-2880 Bagsvaerd, Denmark
  • u00a0NORDITROPIN (Nor-dee-tro-pin)
  • (somatropin) injection for subcutaneous use
  • What is NORDITROPIN?
  • NORDITROPIN is a prescription medicine that contains human growth hormone, the same growth hormone made by the human body.
  • NORDITROPIN is given by injection under the skin (subcutaneous) and is used to treat:
  • Do not use NORDITROPIN if:
  • Before takingu00a0 NORDITROPIN, tell your healthcare provider about all of your medical conditions, including if you:
  • Tell your healthcare provider about all the medicines you take,
  • How should I use NORDITROPIN?
  • What are the possible side effects of NORDITROPIN?
  • NORDITROPIN may cause serious side effects, including:
  • The most common side effects of NORDITROPIN include:
  • These are not all the possible side effects of NORDITROPIN.
  • Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088. You may also report side effects to Novo Nordisk at 1-888-668-6444.
  • How should I store NORDITROPIN?
  • Keep NORDITROPIN and all medicines out of the reach of children.
  • General information about the safe and effective use of NORDITROPIN.
  • Medicines are sometimes prescribed for purposes other than those listed in a Patient Information leaflet. Do not use NORDITROPIN for a condition for which it was not prescribed. Do not give NORDITROPIN to other people, even if they have the same symptoms that you have. It may harm them. You can ask your pharmacist or healthcare provider for information about NORDITROPIN that is written for health professionals.
  • What are the ingredients in NORDITROPIN?
  • Active ingredient:
  • Inactive ingredients:
  • Manufactured by:
  • Novo Nordisk A/S
  • DK-2880 Bagsvaerd, Denmark
  • This Patient Information has been approved by the U.S.Food and Drug Administration.
  • Revised: 02/2018
  • INSTRUCTIONS FOR USE
  • Norditropin (Nor-dee-tro-pin) FlexPron
  • (somatropin) injection
  • 5 mg/1.5 mL Pen
  • Note:
  • Norditropin FlexPron
  • Figure A
  • Supplies you will need for a Norditropin Injection. See Figure A.
  • 6 Steps you should follow for a Norditropin injection:
  • Step 1. Preparing the Norditropin FlexPro Pen
  • Step 2. Attaching the needle to the Norditropin FlexPro Pen
  • Step 3. Priming a new Pen
  • Step 4. Selecting the correct dose of Norditropin
  • Step 5. Selecting the injection site and injecting the dose of Norditropin
  • Step 6. What to do after the injection is completed.
  • Step 1. Preparing the Norditropin FlexPro Pen.
  • Figure B
  • Figure C
  • Figure D
  • Step 2. Attaching the needle to the Norditropin FlexPro Pen.
  • Figure E
  • Figure F
  • Figure G
  • Figure H
  • Step 3. Priming a new Pen.
  • Figure I
  • Figure J
  • Figure K
  • Step 4. Selecting the correct dose of Norditropin.
  • Figure L
  • Important:
  • Step 5. Selecting the injection site and injecting the dose of Norditropin.
  • Figure M
  • If the injection button cannot be pushed in completely or u201c0u201d does not appear in the display window, you did not receive the full dose. Call Novo Nordisk at 1-888-668-6444 for assistance. You may need a new Pen.
  • Important:
  • Figure N
  • Step 6. What to do after the injection is completed.
  • Figure O
  • Care of your Norditropin FlexPro Pen:
  • You must take care of your Norditropin FlexPro Pen:
  • This Instructions for Use has been approved by the U.S. Food and Drug Administration.
  • PATENT Information: http://novonordisk-us.com/patients/products/product-patents.html
  • Norditropinu00ae and FlexProu00ae are registered trademarks of Novo Nordisk Health Care AG.
  • Novo Nordisku00ae is a registered trademark of Novo Nordisk A/S.
  • u00a9 2004-2017 Novo Nordisk Health Care AG
  • For further information contact:
  • Novo Nordisk Inc.
  • 800 Scudders Mill Road
  • Plainsboro, NJ 08536, USA
  • 1-888-668-6444
  • norditropin-us.com
  • Manufactured by:
  • Novo Nordisk A/S
  • DK-2880 Bagsvaerd
  • Denmark
  • Revised: 08/2017
  • INSTRUCTIONS FOR USE
  • Norditropin (Nor-dee-tro-pin) FlexPron
  • (somatropin) injection
  • 10 mg/1.5 mL Pen
  • Note:
  • Norditropin FlexPron
  • Figure A
  • Supplies you will need for a Norditropin Injection. See Figure A.
  • 6 Steps you should follow for a Norditropin injection:
  • Step 1. Preparing the Norditropin FlexPro Pen
  • Step 2. Attaching the needle to the Norditropin FlexPro Pen
  • Step 3. Priming a new Pen
  • Step 4. Selecting the correct dose of Norditropin
  • Step 5. Selecting the injection site and injecting the dose of Norditropin
  • Step 6. What to do after the injection is completed.
  • Step 1. Preparing the Norditropin FlexPro Pen.
  • Figure B
  • Figure C
  • Figure D
  • Step 2. Attaching the needle to the Norditropin FlexPro Pen.
  • Figure E
  • Figure F
  • Figure G
  • If you try to put the needle caps back on, you may accidentally hurt yourself with the needle.
  • Figure H
  • Step 3. Priming a new Pen.
  • Figure I
  • Figure J
  • Figure K
  • Step 4. Selecting the correct dose of Norditropin.
  • Figure L
  • Important:
  • Step 5. Selecting the injection site and injecting the dose of Norditropin.
  • Figure M
  • If the injection button cannot be pushed in completely or u201c0u201d does not appear in the display window, you did not receive the full dose. Call Novo Nordisk at 1-888-668-6444 for assistance. You may need a new Pen.
  • Important:
  • Figure N
  • Step 6. What to do after the injection is completed.
  • Figure O
  • Care of your Norditropin FlexPro Pen:
  • You must take care of your Norditropin FlexPro Pen:
  • This Instructions for Use has been approved by the U.S. Food and Drug Administration.
  • PATENT Information: http://novonordisk-us.com/patients/products/product-patents.html
  • Norditropinu00ae and FlexProu00ae are registered trademarks of Novo Nordisk Health Care AG.
  • Novo Nordisku00ae is a registered trademark of Novo Nordisk A/S.
  • u00a9 2004-2017 Novo Nordisk Health Care AG
  • For further information contact:
  • Novo Nordisk Inc.
  • 800 Scudders Mill Road
  • Plainsboro, NJ 08536, USA
  • 1-888-668-6444
  • norditropin-us.com
  • Manufactured by:
  • Novo Nordisk A/S
  • DK-2880 Bagsvaerd
  • Denmark
  • Revised: 08/2017
  • INSTRUCTIONS FOR USE
  • Norditropin (Nor-dee-tro-pin) FlexPron
  • (somatropin) injection
  • 15 mg/1.5 mL Pen
  • Note:
  • Norditropin FlexPron
  • Figure A
  • Supplies you will need for a Norditropin Injection. See Figure A.
  • 6 Steps you should follow for a Norditropin injection:
  • Step 1. Preparing the Norditropin FlexPro Pen
  • Step 2. Attaching the needle to the Norditropin FlexPro Pen
  • Step 3. Priming a new Pen
  • Step 4. Selecting the correct dose of Norditropin
  • Step 5. Selecting the injection site and injecting the dose of Norditropin
  • Step 6. What to do after the injection is completed.
  • Step 1. Preparing the Norditropin FlexPro Pen.
  • Figure B
  • Figure C
  • Figure D
  • Step 2. Attaching the needle to the Norditropin FlexPro Pen.
  • Figure E
  • Figure F
  • Figure G
  • Figure H
  • Step 3. Priming a new Pen.
  • Figure I
  • Figure J
  • Figure K
  • Step 4. Selecting the correct dose of Norditropin.
  • Figure L
  • Important:
  • Step 5. Selecting the injection site and injecting the dose of Norditropin.
  • Figure M
  • If the injection button cannot be pushed in completely or u201c0u201d does not appear in the display window, you did not receive the full dose. Call Novo Nordisk at 1-888-668-6444 for assistance. You may need a new Pen.
  • Important:
  • Figure N
  • Step 6. What to do after the injection is completed.
  • Figure O
  • Care of your Norditropin FlexPro Pen:
  • You must take care of your Norditropin FlexPro Pen:
  • This Instructions for Use has been approved by the U.S. Food and Drug Administration.
  • PATENT Information: http://novonordisk-us.com/patients/products/product-patents.html
  • Norditropinu00ae and FlexProu00ae are registered trademarks of Novo Nordisk Health Care AG.
  • Novo Nordisku00ae is a registered trademark of Novo Nordisk A/S.
  • u00a9 2004-2017 Novo Nordisk Health Care AG
  • For further information contact:
  • Novo Nordisk Inc.
  • 800 Scudders Mill Road
  • Plainsboro, NJ 08536, USA
  • 1-888-668-6444
  • norditropin-us.com
  • Manufactured by:
  • Novo Nordisk A/S
  • DK-2880 Bagsvaerd
  • Denmark
  • Revised: 08/2017
  • Figure B
  • Figure C
  • Figure D
  • Step 1: Preparing your Pen with PenMate:
  • Wash your hands with soap and water and dry them. Check the name and the colored label on your Pen to make sure it contains the growth hormone strength prescribed by your healthcare provider.
  • Pull off the PenMate cap.
  • See figure E.
  • Figure E
  • You will not need the Pen cap with your PenMate.
  • Figure F
  • Look in the Pen window. Check that the liquid medicine in your Pen is clear and colorless by tipping it upside down 1 or 2 times.
  • See figure G.
  • If the liquid looks cloudy or unclear, do not use the Pen.
  • Figure G
  • Figure H
  • The Pen is correctly attached in your PenMate when the display window on the Pen lines up with the insertion button on your PenMate.
  • Figure I
  • Step 2. Attaching the needle to your Pen:
  • Take a new disposable needle and tear off the paper tab.
  • See figure J.
  • Figure J
  • Holding the Pen with 1 hand, firmly press the needle onto the needle thread of the Pen. Screw the needle in a clockwise direction until the needle will not turn anymore.
  • See figure K.
  • Figure K
  • Pull off the outer needle cap and save it.
  • See figure L.
  • You will need the outer needle cap after the injection so you can safely remove the needle from the Pen.
  • Figure L
  • A drop of liquid may appear at the needle tip. This is normal.
  • Figure M
  • Step 3. Priming a new Pen:
  • Checking the growth hormone flow in the Pen (priming) is not needed for a Pen you have used before. If the Pen has already been primed, go to Step 4.
  • Before you use a new Pen you must prepare it for use. Hold the Pen with 1 hand and turn the dose selector clockwise 1 tick mark to select the n
  • See figure N.
  • You may hear or feel a click when you turn the dose selector.
  • Figure N
  • When you turn the dose selector 1 tick mark, you select the smallest amount of medicine for a dose.
  • See figure O.
  • Figure O
  • This lowest dose will be used for your Norditropin flow check dose.
  • Hold your Pen with PenMate with the needle pointing up. You may see air bubbles in the PenMate window. Gently tap the top of PenMate a few times to let any air bubbles rise to the top.
  • See figure P.
  • Figure P
  • Press the dose button until the dose pointer lines up with the in the display window on the Pen and a drop of liquid appears at the needle tip.
  • See figure Q.
  • Figure Q
  • If no drop of liquid appears at the needle tip,
  • If there is still no drop of liquid at the needle tip, and repeat Step 3 again.
  • If a drop of liquid still does not appear at the needle tip after repeating Step 3 and changing the needle, call Novo Nordisk at 1-888-668-6444 for assistance.
  • Step 4. Selecting the correct dose of Norditropin:
  • Use the dose selector on your Pen to make sure you have the exact dose selected. Your dose will be in a certain number of mg (milligrams).
  • To start, check that the dose pointer on the Pen is set at n
  • Select the dose you need by turning the dose selector clockwise. If you go beyond your dose, turn the dose selector counterclockwise until the right number of mg lines up with the dose pointer. n
  • Figure R
  • To guide you, the dose selector click sound is different when turned clockwise (softer click) or counterclockwise (louder click). You will hear a click for every single unit dialed.
  • When dialing counterclockwise, be careful not to press the dose button as liquid will come out.
  • You can use the growth hormone scale on the side of the Pen to see approximately how much growth hormone is left in the Pen. You can also use the dose selector to see exactly how much growth hormone is left in the Pen.
  • If the Pen contains less than 2 mg, 4 mg, or 8 mg (depending on whether you use a 5 mg, 10 mg, or 15 mg Pen), turn the dose selector until it stops. The number that lines up with the dose pointer shows how many mg are left in the Pen. You cannot set a dose higher than the number of mg left in the Pen.
  • If there is not enough Norditropin left in the Pen for your full dose, use a new Norditropin FlexPro Pen to inject the remaining amount of your dose or contact your healthcare provider.
  • Remember to subtract the dose already received. For example, if the dose is 0.7 mg and you can only set the dose selector to 0.35 mg, you should inject another 0.35 mg with a new Norditropin FlexPro Pen.
  • Important:
  • Do not use the Pen clicks to count the number of mg you select. Only the display window and dose pointer will show the exact number.
  • Do not use the growth hormone scale to measure how much liquid to inject. Only the display window and dose pointer will show the exact number.
  • Step 5. Selecting your injection site and injecting the dose of Norditropin:
  • Change your injection site every day. Select the injection site and wipe your skin with an alcohol swab as your healthcare provider showed you.
  • Norditropin can be injected under your skin (subcutaneously) of your hips, stomach area
  • (abdomen), upper legs (thighs), upper arms, or as otherwise instructed by your healthcare provider.
  • See Figure S.
  • Arrayn- Array
  • Figure S
  • Hold onto both the PenMate and your Pen without touching the insertion button on the PenMate the dose button on the Pen.
  • Do not press the insertion button on the PenMate before you are ready to inject your dose.
  • Hold the PenMate firmly with 1 hand and pull the Pen out with your other hand until you hear and feel a click. n
  • The needle is now hidden in PenMate.
  • Figure T
  • Norditropin is for use under your skin only (subcutaneous). Hold the PenMate against your skin. Press the insertion button on the PenMate until you hear or feel a click.
  • When you hear or feel the click, the needle has been inserted automatically into your skin.
  • See figure U.
  • You are now ready to inject your dose.
  • Figure U
  • Press the dose button on the Pen to inject your dose. Do not
  • Make sure you can see the display window. n cover it with your fingers.
  • Press and hold down the dose button on the Pen until the display window returns to u201c0u201d.
  • The must line up with the dose pointer. You may then hear or feel a firm click.
  • See figure V
  • Figure V
  • If the dose button cannot be pushed in completely or u201c0u201d does not appear in the display window, you did not receive the full dose. Call Novo Nordisk at
  • 1-888-668-6444 for assistance. You may need a new Pen.
  • After the display window has returned to u201c0u201d, leave the needle under your skin for at least 6 seconds
  • See figure V.
  • Let go of the dose button while you wait.
  • Important:
  • Always press the dose button to inject the dose. Turning the dose selector will not inject the dose.
  • Do not touch the display window when you inject, as this can block the injection.
  • Carefully lift the Pen to remove the needle from the skin.
  • See figure W.
  • Figure W
  • Carefully put the outer needle cap back on the needle.
  • Remove the needle from the Pen after each injection.
  • See figure X.
  • Figure X
  • Unscrew the needle by turning it counterclockwise. Do not touch the needle. Hold the Pen with 1 hand and carefully remove the needle from the Pen with your other hand.
  • See figure Y.
  • Dispose of the needle as directed by a healthcare provider. See at the end of these instructions.
  • Figure Y
  • Put the PenMate cap back on your PenMate after each use to protect the growth hormone from light.
  • See figure Z.
  • Figure Z
  • Important safety information to remember:
  • How should I replace an empty Pen?
  • PenMate is reusable
  • When your Pen is empty, until you hear or feel a click.
  • See figure AA.
  • Figure AA
  • Gently pull the Pen out of PenMate.
  • See figure BB.
  • Before disposing of your empty Pen, make sure the needle has been removed. Dispose of the empty Pen as recommended by your healthcare provider. See at the end of these instructions.
  • Figure BB
  • Insert the new Pen into your PenMate.
  • See figure CC.
  • Figure CC
  • Twist the Pen until you hear or feel a click.
  • See figure DD.
  • The Pen is correctly attached in your PenMate when the display window on the Pen lines up with the insertion button on your PenMate.
  • Figure DD
  • How should I store my PenMate and Pen?
  • How should I care for and clean my Pen with PenMate?
  • How should I dispose of my Pen and needles?
  • Need help?
  • PenMate must only be used according to the instructions provided. The manufacturer cannot be held responsible for any problems with PenMate if these instructions have not been followed.
  • If you find that your PenMate or case is defective, make sure to have Novo Nordisk replace it. Call the number below to order a new PenMate or case and arrange return of the defective item for inspection.
  • For assistance or further information, write to:
  • Novo Nordisk Inc.
  • 800 Scudders Mill Road
  • Plainsboro, NJ 08536, USA
  • Visit norditropin-us.com
  • Or call: 1-888-668-6444
  • PATENT Information: http://novonordisk-us.com/patients/products/product-patents.html
  • Novo Nordisk, PenMate and NovoFine are registered trademarks of Novo Nordisk A/S.
  • Norditropin and FlexPro are registered trademarks of Novo Nordisk Health Care AG.
  • u00a9 2015-2017 Novo Nordisk A/S
  • This Instructions for Use has been approved by the U.S. Food and Drug Administration.
  • Manufactured by:
  • Novo Nordisk A/S
  • Novo Allu00e9
  • DK-2880 Bagsvu00e6rd
  • Denmark
  • Revised: 08/2017
  • Norditropinu00a0 FlexPron
  • (somatropin) injection
  • 5 mg/1.5 mL Prefilled Pen
  • 1 x 1.5 mL prefilled disposable pen
  • Each 1.5 mL contains 5 mg somatropin
  • CONTAINS ONE
  • NORDITROPIN FlexPro 5 mg/1.5 mL
  • Single patient use only
  • Rx only
  • NDC 0169-7704-21
  • List: 770421
  • Norditropinu00a0 FlexPron
  • (somatropin) injection
  • 10 mg/1.5 mL Prefilled Pen
  • 1 x 1.5 mL prefilled disposable pen
  • Each 1.5 mL contains 10 mg somatropin
  • CONTAINS ONE
  • NORDITROPIN FlexPro 10 mg/1.5 mL
  • Single patient use only
  • Rx only
  • NDC 0169-7705-21
  • List: 770521
  • Norditropinu00a0 FlexPron
  • (somatropin) injection
  • 15 mg/1.5 mL Prefilled Pen
  • 1 x 1.5 mL prefilled disposable pen
  • Each 1.5 mL contains 15 mg somatropin
  • CONTAINS ONE
  • NORDITROPIN FlexPro 15 mg/1.5 mL
  • Single patient use only
  • Rx only
  • NDC 0169-7708-21
  • List: 770821
  • Norditropinn
  • (somatropin) injection
  • 30 mg / 3 mLPrefilled Pen
  • 1x3 mL prefilled pen
  • Each 3 mL contains: 30 mg somatropin
  • CONTAINS ONE NORDITROPIN FlexPro 30 mg / 3 mL
  • Single patient use only
  • Rx only
  • NDC 0169-7703-21
  • List: 770321

Ask for Quote

Browse Our Services And Processes

Name Patient Supply

Name Patient Supply

Validated Cold Chain Shipment

Validated Cold Chain Shipment

Comparator Sourcing for Clinical Trials

Comparator Sourcing for Clinical Trials

Our Process - The Gnh Way

Our Process - The Gnh Way

Other Pharmaceutical Products

Rocufine - Rocuronium Bromide

Rocufine - Rocuronium Bromide

Paclitaxel - Abraxane

Paclitaxel - Abraxane

Liposomal Amphotericin - B for Injection IP (AmBisome)

Liposomal Amphotericin - B for Injection IP (AmBisome)

Edatate Calcium Disodium Injection USP 200mg/ml (Cal-Rsodate)

Edatate Calcium Disodium Injection USP 200mg/ml (Cal-Rsodate)

Melphalan Injection IP 50mg (Alkacel)

Melphalan Injection IP 50mg (Alkacel)

Monobenzone Cream USP 20% (Albaquin)

Monobenzone Cream USP 20% (Albaquin)

Are you an existing customer or a vendor of GNH India? Log in here to